Evidence map›Paper›PMID 39261435›Full record

ReviewAdvances in experimental medicine and biology2024

The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients.

Junhyung Kim, Yong-Ku Kim

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Junhyung KimDepartment of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yong-Ku KimDepartment of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. yongku@korea.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virtual reality (VR) is a promising supplemental or alternative approach for treating depression. Focusing on the unique affordances of VR, such as immersive therapeutic settings and uniform treatment delivery, this study explores both the current applications and future potential of VR technology in treating and assessing depression. VR provides users with an "immersive" and "presence" experience through multisensory stimulation. VR is an emerging paradigm in healthcare, particularly in psychiatric treatment, and presents compelling possibilities for its role in therapeutic interventions by facilitating realistic and controlled environments for both clinicians and patients. VR technology offers promising advancements in augmenting traditional cognitive-behavioral therapy (CBT) methods for treating depression, with applications in psychoeducation, behavioral activation, and cognitive restructuring. Various VR assessment techniques including biomarkers and machine learning have been discussed in this study. Although the field remains experimental, the immersive nature of VR holds the potential for more personalized and accurate therapeutic interventions and assessments. Further research is required for definitive conclusions.

Indexed as

Cognitive Behavioral TherapyDepressionVirtual RealityHumansVirtual Reality Exposure Therapybehavior therapyCognitiveDepressionEmbodimentVirtual reality

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.